Skip to main content
CELZ logo

Creative Medical Technology Holdings, Inc.

CELZNASDAQHealthcareBiotechnology

$0.74Today:- (-)1Y −77.22%

As of Oct 16, 2026 close

Market cap
$3.03M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.62$6.25
Volume (live)
-
Avg. volume (3M)
876.88K

Creative Medical Technology Holdings (CELZ) Financial Ratios

For fiscal 2025 (fiscal year ended Dec 31, 2025), Creative Medical Technology Holdings had return on equity of -86.5% (down from -65.8%), debt-to-equity of 0.00 (unchanged), a current ratio of 25.97 (up from 18.73) and return on assets of -53.0% (down from -41.3%). A current ratio of 25.97 means current assets exceed current liabilities.

Creative Medical Technology Holdings Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio----0.73-
P/S Ratio1141.59367.17707.9660.55159.35101.69
P/B Ratio0.910.640.620.341.37-0.42
Price/Tangible Book0.960.690.640.351.44-
Enterprise Value Ratios
EV/Revenue248.04---163.74107.06
Profitability & Returns
Return on Equity (ROE)-86.47%-65.85%-40.34%-77.78%--
Return on Assets (ROA)-53.03%-41.30%-23.49%-42.05%-32.60%-111.61%
Return on Capital Employed (ROCE)-81.60%-90.60%-54.30%-64.60%-30.60%2.80%
Leverage & Solvency Ratios
Debt/Equity0.000.000.000.000.00-0.02
Liquidity Ratios
Current Ratio25.9718.7327.665.6410.220.00
Quick Ratio25.3018.1326.895.5410.210.00
Efficiency Ratios
Asset Turnover0.000.000.000.010.010.26
Inventory Turnover-1.000.432.71--
Yield & Distribution Ratios
Earnings Yield-87.52%-136.01%-82.97%-189.10%137.39%-217.15%
Buyback Yield-60.95%-5.17%-28.76%-236.51%-460.63%-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Creative Medical Technology Holdings Financial Ratios

What is Creative Medical Technology Holdings's return on equity?

Creative Medical Technology Holdings's return on equity (ROE) was -86.5% for fiscal 2025 (period ended Dec 31, 2025). It was -65.8% a year earlier.

What is Creative Medical Technology Holdings's debt-to-equity ratio?

Creative Medical Technology Holdings's debt-to-equity ratio was 0.00 for fiscal 2025 (period ended Dec 31, 2025). It was 0.00 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition